Telix agrees $73m asset acquisition with US biotech ImaginAb - Capital Brief

Retrieved on: 2025-01-12 22:03:23

Tags for this article:

Medical physics

Radiobiology

Radiation therapy

Radioactivity

Telix

Click the tags to see associated articles and topics

Telix agrees $73m asset acquisition with US biotech ImaginAb - Capital Brief. View article details on hiswai:

Summary

The article discusses Telix's acquisition of intellectual property and a research facility, enhancing its biotech capabilities in radiopharmaceuticals. This aligns with the tags, focusing on medical physics, radiobiology, and treatments using radioactivity.

Article found on: www.capitalbrief.com

View Original Article